On the contrary, from 12 patients with MLD as a single criterion for the diagnosis of AML-MRC, only 3 lacked MR mutations (two AML-DD/NOS after reclassification and one AML-NUP98). The gene discussed is NR3C2; the disease is acute myeloid leukemia.